BCTX BriaCell Therapeutics Corp.
$3.50▼ -0.14%
Healthcare
Other
Volume 6.6K
Avg Volume (10D) 57.0K
Key Metrics & Fundamentals
Market Cap
$30.41M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.60 - 13.80
% vs 50 MA
-7.81%
% vs 200 MA
-10.26%
RSI-14
42.1
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.94
Free Cash Flow
-$7.15M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.43M
COGS
–
Operating Exp
$7.62M
Operating Income
-$7.62M
EBIT
-$7.62M
Pretax Income
-$7.24M
Net Income
-$7.16M
EPS (Diluted)
-0.99
Price & Volume History
Loading chart…
Recent News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
GlobeNewswire · Oct 23, 2026 7:30 AM ET
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
GlobeNewswire · Oct 6, 2026 7:30 AM ET
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
GlobeNewswire · Sep 14, 2026 7:30 AM ET
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
GlobeNewswire · Sep 8, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BCTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.